Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Instagram Outage Disrupts Thousands of U.S. Users 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
WATERBURY, Conn., March 06, 2018 -- Northeast Scientific Inc. (NES) has released 5-year results proving that the use of their reprocessed medical devices is safe, effective and smart. NES has successfully supplied 250,000 reprocessed VNUS ClosureFast RF Ablation Catheters with no adverse events and exceptional physician savings.
Proven Performance
- Less than 0.25% (less than 1 in 400) of NES reprocessed devices are returned for performance failure.
- NES inspects every single device, not just a sampling like most OEMs.
- Any user who is not happy with the device for any reason is given full credit.
Excellent Safety Record
NES has supplied the reprocessed device for more than 5 years with NO ADVERSE EVENTS.
Search for the keyword “closurefast” on the FDA MAUDE database to see all adverse events involving the ClosureFast catheter.
Smart Doctors
Search online for doctors who use the NES reprocessed catheter and consult with other physicians: Reprocessing makes strong financial sense for the practice. Some save more than $100,000 each year on devices alone.
Simple math
Doctors pay on average 35% less for the reprocessed VNUS ClosureFast Catheter, and the savings compound with increased use of NES devices.
35% savings with a device that is proven safe and effective by doctors across the country.
Visit www.smarthealth-care.com to learn more about Northeast Scientific Inc. Come see the operation in Waterbury, CT. Call anytime with any questions 203.756.2111.
Watch a video about NES here https://www.smarthealth-care.com/about-us/
See what else NES does here – www.worldpace.org
About Northeast Scientific
Northeast Scientific, Inc. (NES), in Waterbury, Connecticut, is registered with the U.S. Food and Drug Administration as both a reprocessor of single-use medical devices and a manufacturer. Founded in 2005, NES received its first 510(k) clearance in 2007, has added new products to its reprocessing suite and is developing multiple 510ks in the vascular space. NES is ISO 13485 2016 Certified.
Northeast Scientific Inc. Media Contact
Scott Allmendinger 203.756.2111
